ChiCTR2500106774 版本V1.0 版本创建时间2025/07/30 09:22:06 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500106774 

最近更新日期:

Date of Last Refreshed on:

2025-07-30 09:21:49 

注册时间:

Date of Registration:

2025-07-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

局部神经阻滞联合全身麻醉对腹腔镜手术患者麻醉效果的研究

Public title:

Study on the Anesthetic Effect of Local Nerve Block Combined with General Anesthesia in Patients Undergoing Laparoscopic Surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

局部神经阻滞联合全身麻醉对腹腔镜手术患者麻醉效果的研究

Scientific title:

Study on the Anesthetic Effect of Local Nerve Block Combined with General Anesthesia in Patients Undergoing Laparoscopic Surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张晓静 

研究负责人:

张晓静 

Applicant:

Zhang Xiaojing 

Study leader:

Zhang Xiaojing 

申请注册联系人电话:

Applicant telephone:

+86 151 9589 2614

研究负责人电话:

Study leader's telephone:

+86 151 9589 2614

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1079136203@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1079136203@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省南京市江宁区龙眠大道109号

研究负责人通讯地址:

江苏省南京市江宁区龙眠大道109号

Applicant address:

109 Longmian Avenue, Jiangning District, Nanjing, Jiangsu

Study leader's address:

109 Longmian Avenue, Jiangning District, Nanjing, Jiangsu

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南京医科大学附属逸夫医院

Applicant's institution:

Sir Run Run Hospital Affiliated to Nanjing Medical University

研究负责人所在单位:

南京医科大学附属逸夫医院

Affiliation of the Leader:

Sir Run Run Hospital Affiliated to Nanjing Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2024-SR-020

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南京医科大学附属逸夫医院伦理委员会

Name of the ethic committee:

Ethics Committee of Sir Run Run Hospital Affiliated to Nanjing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-12-02 00:00:00

伦理委员会联系人:

刘雯

Contact Name of the ethic committee:

Liu Wen

伦理委员会联系地址:

江苏省南京市江宁区龙眠大道109号

Contact Address of the ethic committee:

109 Longmian Avenue, Jiangning District, Nanjing, Jiangsu

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 8711 5593

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南京医科大学附属逸夫医院

Primary sponsor:

Sir Run Run Hospital Affiliated to Nanjing Medical University

研究实施负责(组长)单位地址:

江苏省南京市江宁区龙眠大道109号

Primary sponsor's address:

109 Longmian Avenue, Jiangning District, Nanjing, Jiangsu

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

南京市

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

南京医科大学附属逸夫医院

具体地址:

江苏省南京市江宁区龙眠大道109号

Institution
hospital:

Sir Run Run Hospital Affiliated to Nanjing Medical University

Address:

109 Longmian Avenue, Jiangning District, Nanjing, Jiangsu

经费或物资来源:

自筹

Source(s) of funding:

self-financing

Target disease:

None

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1 观察不同配方麻醉药物在神经阻滞中的应用效果; 2 根据试验结果选择出合适剂量麻醉药物用于神经阻滞; 3 根据试验结果优化神经阻滞方案  

Objectives of Study:

1. Observe the application effects of different formulations of anesthetic drugs in nerve block; 2. Select the appropriate dosage of anesthetic drugs based on the test results for nerve block; 3. Optimize the nerve block protocol based on the test results.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.接受神经阻滞进行腹腔镜手术患者; 2.有完整临床记录的18-85岁患者; 3.美国麻醉医师协会(ASA)麻醉风险分级I-III。

Inclusion criteria

1. Patients undergoing laparoscopic surgery with nerve block; 2. Patients aged 18-85 with complete clinical records; 3. American Society of Anesthesiologists (ASA) anesthesia risk classification I-III.

排除标准:

1.有试验药物过敏史的患者; 2.麻醉禁忌证者; 3.有心、肺、肝、肾、血液等重要系统疾病的患者; 4.有沟通障碍或认知障碍的患者。

Exclusion criteria:

1. Patients with a history of drug allergy to experimental drugs; 2. Those with contraindications to anesthesia; 3. Patients with diseases in important systems such as heart, lungs, liver, kidneys, and blood; 4. Patients with communication disorders or cognitive impairments.

研究实施时间:

Study execute time:

From 2025-08-01 00:00:00 To 2028-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-08-08 00:00:00 To 2028-07-31 00:00:00  

干预措施:

Interventions:

组别:

A组

样本量:

40

Group:

GroupA

Sample size:

干预措施:

神经阻滞选择罗哌卡因

干预措施代码:

Intervention:

Neural block is selected with ropivacaine.

Intervention code:

组别:

B组

样本量:

40

Group:

Group B

Sample size:

干预措施:

神经阻滞选择罗哌卡因+右美托咪定

干预措施代码:

Intervention:

Nerve block selected with ropivacaine + dexmedetomidine

Intervention code:

组别:

C组

样本量:

40

Group:

Group C

Sample size:

干预措施:

神经阻滞选择罗哌卡因+右美托咪定+艾司氯胺酮

干预措施代码:

Intervention:

Nerve block selection: ropivacaine + dexmedetomidine + eszopiclone

Intervention code:

组别:

D组

样本量:

40

Group:

Group D

Sample size:

干预措施:

神经阻滞选择罗哌卡因+艾司氯胺酮

干预措施代码:

Intervention:

Nerve block selected with ropivacaine + esoximide

Intervention code:

组别:

E组

样本量:

40

Group:

Group E

Sample size:

干预措施:

神经阻滞选择生理盐水

干预措施代码:

Intervention:

Neural block is selected with normal saline.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏省  

市(区县):

南京 

Country:

China 

Province:

Jiangsu 

City:

Nanjing 

单位(医院):

南京医科大学附属逸夫医院  

单位级别:

三级 

Institution
hospital:

Sir Run Run Hospital Affiliated to Nanjing Medical

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

血压

指标类型:

主要指标

Outcome:

Blood pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

主要指标

Outcome:

Heart rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血氧饱和度

指标类型:

主要指标

Outcome:

Blood oxygen saturation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

神经阻滞起效时间

指标类型:

主要指标

Outcome:

Onset time of nerve block

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

神经阻滞持续时间

指标类型:

主要指标

Outcome:

Duration of nerve block

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

镇痛药物用量

指标类型:

主要指标

Outcome:

Dosage of postoperative analgesics

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后疼痛评分

指标类型:

主要指标

Outcome:

Postoperative pain score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

恶心呕吐

指标类型:

次要指标

Outcome:

Nausea and vomiting

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后不良反应

指标类型:

次要指标

Outcome:

Postoperative adverse reaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后恢复质量

指标类型:

次要指标

Outcome:

Postoperative recovery quality

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血液检验指标

指标类型:

次要指标

Outcome:

Blood test indicators

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术时间

指标类型:

次要指标

Outcome:

Duration of operation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

麻醉时间

指标类型:

次要指标

Outcome:

Duration of anesthesia

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由不参与本研究的一名麻醉护士采用随机抽签方式决定患者分组

Randomization Procedure (please state who generates the random number sequence and by what method):

The anesthesia nurse who is not involved in this research, uses a random lottery method to determine the grouping of patients

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

双盲(负责用药的麻醉医师和受试患者均不知道用药方案)

Blinding:

Double blinded (Neither the administering anesthesiologist nor the subject patient knew the medication regimen)

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-07-30 09:21:49